Neurocrine Biosciences reported $7.7M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 4.17B 57M
Acadia Pharmaceuticals ACAD:US USD 2.41M 277K
Acorda Therapeutics ACOR:US USD 4.56M 6.44M
Agios Pharmaceuticals AGIO:US USD 413K 104K
ALKERMES ALKS:US USD 53.96M 3.34M
Alnylam Pharmaceuticals ALNY:US USD 51.27M 10.15M
Amgen AMGN:US USD 1.75B 159M
Biogen BIIB:US USD 570.9M 101.4M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Dynavax Technologies DVAX:US USD 77.49M 16.15M
Exelixis EXEL:US USD 15.92M 615K
Gilead Sciences GILD:US USD 1.4B 1000K
Halozyme Therapeutics HALO:US USD 42.12M 5.2M
Intercept Pharmaceuticals ICPT:US USD 28K 396K
Intra Cellular Therapies ITCI:US USD 6.79M 938K
IONIS PHARMACEUT IONS:US USD 3.69M 2.17M
Nektar Therapeutics NKTR:US USD 6.23M 1.26M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Pfizer PFE:US USD 9.82B 3.73B
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Repligen RGEN:US USD 90.7M 4.19M
Rigel Pharmaceuticals RIGL:US USD 342K 92K
Sarepta Therapeutics SRPT:US USD 30.8M 9.15M
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
Ultragenyx Pharmaceutical RARE:US USD 5.32M 3.31M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M
YTE INCY:US USD 53.76M 4.48M